Olema Pharmaceuticals (OLMA) Change in Acquisitions & Divestments (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $74.5 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 23.83% year-over-year to $74.5 million in Q1 2026; TTM through Mar 2026 was $321.7 million, a 6.29% decrease from a year earlier, with the FY2025 full-year figure at $345.0 million, up 14.38% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $74.5 million, down from $91.2 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for OLMA reached as high as $148.8 million in Q1 2022 and fell as low as $38.8 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $75.1 million across 5 years, with a median of $70.5 million in 2023.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 14775.0% in 2022 and fell as far as 67.56% in 2022.
• Year by year, Change in Acquisitions & Divestments stood at $61.0 million in 2022, then decreased by 11.48% to $54.0 million in 2023, then jumped by 38.53% to $74.8 million in 2024, then grew by 21.87% to $91.2 million in 2025, then fell by 18.32% to $74.5 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $74.5 million in Q1 2026, $91.2 million in Q4 2025, and $88.9 million in Q3 2025.